Home・Stock List・Insulet Corp

Insulet Corp

Closed

SectorHealthcare

132.62 -20.36

Buy Sell

Overview

Share price change

24h

Current

Min

164.35

Max

170.86

Key metrics
By Trading Economics
Income	-11M 91M
Sales	-22M 762M
P/E Sector Avg	38.551 64.641
EPS	1.42
Profit margin	11.96
Employees	5,400
EBITDA	-23M 154M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+30.45% upside

Dividends
By Acuity
Next Earnings	5 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-442M 11B
Previous open	152.98
Previous close	132.62

News Sentiment

By Acuity

83%

17%

312 / 340 Healthcare

Insulet Corp Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 Jul 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 Jul 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 Jul 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 Jul 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 Jul 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 Jul 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 Jul 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Peer Comparison

Price change

Insulet Corp Forecast

Price Target

By TipRanks

30.45% upside

12 Months Forecast

Average 221.38 USD 30.45%

High 294 USD

Low 172 USD

Based on 22 Wall Street analysts offering 12 month price targets forInsulet Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

22 ratings

Buy

Hold

Sell

Based on 22 analysts giving stock ratings to Insulet Corp - Dist in the past 3 months.

Sentiment

By Acuity

312 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.